Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 847-853

  Nguyen, Phuong L ^a   Harris, Nancy L ^a   Ritz, Jerome ^b   Robertson, Michael J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2;

ANIMAL; ARTICLE; B CELL LYMPHOMA; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; NONHODGKIN LYMPHOMA; PATHOLOGY; T CELL LYMPHOMA;

ANIMALS; ANTIGENS, CD95; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0030091222     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis Science 1989; 245 301-305
2. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-1756
3. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I Sarneshima M, Hase A, Seto Y, Nagata S: The polypeplide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 1991; 66 233-243
4. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer PH. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor superfamily J Biol Chem 1992, 267.10709-10715
5. Robertson MJ, Ritz J Cluster report CD95 Leukocyte Typing V. White Cell Differentiation Antigens Edited by SF Schlossman, L Boumsell, W Gilks, JM Harlan T Kishimoto, C Morimoto, J Ritz, S Shaw, RL Silverstein TA Springer, TF Tedder, RF Todd. Oxford, Oxford University Press (in press)
6. Lichter P, Walczak H, Weitz S, Behrmann I, Krammer PH: The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with the mouse chromosome 19 Genomics 1992; 14.179-180
7. Suda T, Takanashi T, Golstein P, Nagata S Molecular cloning and expression of the Fas ligand. a novel member of the tumor necrosis factor family Cell 1993, 75 1169-1176
8. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M. Expression and structure of the human NGF receptor Cell 1986; 47:545-554
9. Stamencovic I, Clark E, Seed B' A B-cell activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas EMBO J 1989; 8 1403-1410
10. Loetscher H, Pan Y-C, Lahm H-W, Bentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55-kd tumor necrosis factor receptor. Cell 1990; 61:351-359
11. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Trace H, Wong W, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Doedded DV Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990; 61:361-370
12. Camerini D, Walz G. Loenen WAM, Borst J, Seed B The T-cell activation antigen CD27 is a member of NGF/TNF receptor gene family J Immunol 1991, 147: 3165-3169
13. Durkp H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992, 68:421-427
14. Gruss H-J, Dower SK. Tumor necrosis factor ligand superfamily involvement in the pathology of malignant lymphomas. Blood 1995; 85:3378-3404
15. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992, 149.3753-3758
16. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils Blood 1994; 84 1201-1208
17. Yoshino T, Kondo E. Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral blood T and B lymphocytes. Blood 1994, 83:856-1861
18. Moller P, Henne C, Leithauser F, Eichelmann A, Schmidt A, Bruderlein S, Dhein J, Krammer PH Co-regulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B-cells and coordinate expression in follicular center B-cells and in follicle center and mediastinal B-cell lymphomas. Blood 1993; 81 2067-2075
19. Leithauser F, Dhein J, Mechtesheimer G, Koretz K, Bruderlelin S, Henne C, Schmidt A, Debatin K-L, Krammer PH, Moller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69 415-429
20. Debatin K-L, Goldmann CK, Bamford R, Waldmann TA, Krammer PH Monoclonal-antibody-mediated apoptosts in adult T-cell leukemia. Lancet 1990; 335:497-500
21. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992, 140:197-205
22. Klas C, Debatin K-M Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells Int Immunol 1993; 5.625-630
23. Falk MH, Trauth BC, Debatin K-M, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH, Bornkamm GW: Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype Blood 1992, 79:3300-3306
24. Kondo E, Yoshino T, Yamadori I, Matsuo Y, Kawasaki N, Minowada J, Akagi T- Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol 1994; 145:330-337
25. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621-627
26. Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K, Kishimoto T: Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis Blood 1995, 85:757-764
27. Robertson MJ, Manley TJ, Pichert G, Cameron C, Cochran KJ, Levine H, Ritz J Functional consequences of APO-1/Fas antigen expression by normal and neoplastic hematopoietic cells. Leuk & Lymphoma 1995; 17:51-61
28. Mapara MY, Bargou R, Zugck, Dohner H, Ustaoglu F, Jonker RR, Krammer PA, Dorken B. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia, correlation with bcl-2 oncogene expression. Eur J Immunol 1993; 23:702-708
29. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelmk H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke R A revised European-American classification of lymphoid neoplasms a proposal from the international lymphoma study group. Blood 1994, 84:1361-1392
30. Harris NL, Kata RE: The distinction of neoplastic and normal B-lymphoid cells in nodular lymphomas: use of an immunoperoxidase technique on frozen sections. Hum Pathol 1982: 13:610-617
31. Ferry J, Linggood R, Convery K, Efird J, Eliseo R, Harris N: Hodgkin's disease, nodular sclerosis type: implications of histologic subclassification. Cancer 1993; 71. 457-463
32. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A, Krammer PH Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 1994; 57:371-377
33. Munker R, Lubbert M, Yonehara S, Tuchnitz A, Mertelsmann R, Wilmanns W Expression of the Fas antigen on primary human leukemia cells Ann Hematol 1995; 70: 15-17
34. Xerri L, Carbuccia N, Parc P, Hassoun J, Birg F: Expression of the Fas/APO-1 gene in Reed-Sternberg cells and anaplastic large cell lymphomas. VII Meeting of the European Association for Haematopathology (1994, Toledo, Spain) (abstr )